Smaller diameter gliomas have been shown to have lower expression of MMP-2, whereas MMP-2 is highly expressed in larger diameter malignant gliomas, with a corresponding decrease in expression of a group of inhibitory proteins, tissue inhibitors of metalloproteinases (TIMPs) [21]. The gene discussed is MMP2; the disease is central nervous system cancer.